Phrontline Biopharma Company
Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.
Employee Number:
11-50
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2022-01-01
Industry:
Advanced BioTech R&D
Sub-Industry:
PharmTech
Investors:
Decheng Capital, Med-Fine Capital, Samsung Venture Investment, Sino Biopharmaceutical, Hankang Capital
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China